We are live on
!
Find out more
MU
Mirova US Portfolio holdings
AUM
$8.81B
1-Year Est. Return
21.38%
This Fund
S&P 500
This Quarter
Est. Return
+7.2%
1 Year Est. Return
+21.38%
3 Year Est. Return
+80.7%
5 Year Est. Return
+106.85%
10 Year Est. Return
–
AUM
$738M
AUM Growth
–
Cap. Flow
+$704M
Cap. Flow
% of AUM
95.37%
Top 10 Holdings %
Top 10 Hldgs %
73.4%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$67.4M |
| 2 |
Mastercard
MA
|
+$66.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$61.8M |
| 4 |
Danaher
DHR
|
+$55.3M |
| 5 |
Ecolab
ECL
|
+$50.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.6% |
| 2 | Healthcare | 20.2% |
| 3 | Financials | 18.7% |
| 4 | Utilities | 9.03% |
| 5 | Materials | 7.12% |
Similar funds
MERSOM
CFB
MOACM
SWP
CB
WT
OAM
PEA
Mirova US's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Mirova US, which disclosed 32 positions worth $738M. Its ten largest holdings account for 73% of the portfolio.
Its largest position is Microsoft: 458,815 shares worth $72.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Healthcare and Financials.
- Mirova US's largest Q4 2019 buy was Microsoft: 458,815 shares worth $72.4M.
- Mirova US's ten largest holdings make up 73% of its $738M portfolio in Q4 2019.
- Mirova US disclosed 32 positions in Q4 2019, its first 13F filing on record.
Based on Mirova US's 13F filing for Q4 2019, filed 14 Feb 2020.